Literature DB >> 692746

The effect of thyroid hormone on serotonergic neurones: depletion of serotonin in discrete brain areas of developing hypothyroid rats.

R B Rastogi, R L Singhal.   

Abstract

A single intraperitoneal injection of 131I in a dose of 200muCi in 1-day-old rats induced hypothyroidism and decreased the activity of tryptophan hydroxylase in mid-brain region. The levels of 5-hydroxytryptamine also were reduced in cerebellum, mid-brain and striatum by 22%, 29% and 31%, respectively. By contrast, the levels of its metabolite, 5-hydroxyindoleacetic acid, were significantly increased in cerebellum, mid-brain and striatal region. To ascertain whether changes induced by neonatal radiothyroidectomy were specific, the effect of replacement thyroid hormone therapy was studied on 5-hydroxytryptamine metabolism. Daily administration of L-triiodothyronine (10 microgram/100g s.c.) for 25 days beginning from five days after radio-iodine treatment enhanced tryptophan hydroxylase activity, tryptophan and 5-hydroxytryptamine levels to values seen in normal rats of the corresponding age group. The concentration of 5-hydroxyindoleacetic acid decreased following L-triiodothyronine treatment. Furthermore, when replacement therapy with L-triiodothyronine was postponed until adulthood, no significant effects could be seen on various parameters related to 5-hydroxytryptamine metabolism. Our data demonstrate that deficiency of thyroid hormone in early life disrupts the normal upsurge of 5-hydroxytryptamine metabolism in brain. A critical period exists in early life of rats during which thyroid hormone must be present for the optimal development of 5-hydroxytryptamine metabolizing systems in maturing brain.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 692746     DOI: 10.1007/BF00501371

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  20 in total

1.  Evidence for the role of brain biogenic amines in depressed motor activity seen in chemically thyroidectomized rats.

Authors:  R B Rastogi; Y Lapierre; R L Singhal
Journal:  J Neurochem       Date:  1976-03       Impact factor: 5.372

Review 2.  Brain biogenic amines and altered thyroid function.

Authors:  R L Singhal; R B Rastogi; P D Hrdina
Journal:  Life Sci       Date:  1975-12-01       Impact factor: 5.037

3.  MITOCHONDRIAL DIFFERENCES IN MATURE AND IMMATURE BRAIN; INFLUENCE ON RATE OF AMINO ACID INCORPORATION INTO PROTEIN AND RESPONSES TO THYROXINE.

Authors:  C B KLEE; L SOKOLOFF
Journal:  J Neurochem       Date:  1964-10       Impact factor: 5.372

4.  Thyroid hormone control of 5-hydroxytryptamine metabolism in developing rat brain.

Authors:  R B Rastogi; R L Singhal
Journal:  J Pharmacol Exp Ther       Date:  1974-10       Impact factor: 4.030

5.  Influence of thyroid on formation of myelin lipids.

Authors:  P Walravens; H P Chase
Journal:  J Neurochem       Date:  1969-10       Impact factor: 5.372

6.  Mechanisms for the elimination of 5-hydroxyindoleacetic acid from brain and cerebrospinal fluid of the rat during postnatal development.

Authors:  C Atack; N H Bass; P Lundborg
Journal:  Brain Res       Date:  1974-08-30       Impact factor: 3.252

Review 7.  Thyroid and central nervous development.

Authors:  J T Eayrs
Journal:  Sci Basis Med Annu Rev       Date:  1966

8.  Changes in weight and volume of rat spinal cord motor neurons with increasing age.

Authors:  D H Ford; G Cohan
Journal:  Acta Anat (Basel)       Date:  1968

9.  Tryptophan hydroxylase inhibition: the mechanism by which p-chlorophenylalanine depletes rat brain serotonin.

Authors:  E Jéquier; W Lovenberg; A Sjoerdsma
Journal:  Mol Pharmacol       Date:  1967-05       Impact factor: 4.436

10.  Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in rat brain.

Authors:  R B Rastogi; R L Singhal
Journal:  J Pharmacol Exp Ther       Date:  1976-09       Impact factor: 4.030

View more
  1 in total

1.  Tryptophan hydroxylase-2: an emerging therapeutic target for stress disorders.

Authors:  Guo-Lin Chen; Gregory M Miller
Journal:  Biochem Pharmacol       Date:  2013-02-19       Impact factor: 5.858

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.